Results of a real-world study on vortioxetine in patients with major depressive disorder in South East Asia (REVIDA)

Current Medical Research and Opinion
Cheuk Ngen ChinLars Nelleman

Abstract

The REVIDA study aimed to assess the evolution of major depression symptoms in South East Asian (SEA) patients treated with vortioxetine for major depression in real-world clinical practice. This non-interventional study was conducted from August 2016 to April 2017. A total of 138 patients (aged 18-65 years) with an active episode of major depression were recruited from Malaysia, Philippines, Singapore and Thailand. Vortioxetine was initiated on the first visit and patients were followed for 3 months. Depression severity was assessed using the PHQ-9 questionnaire (patient assessed) and CGI-S scale (physician assessed); cognitive function was assessed with the PDQ-D questionnaire; work productivity and activity impairment (WPAI) was assessed with the WPAI questionnaire. At baseline, 89.9% of patients were moderately to severely depressed (PHQ-9 score ≥10). During the 3 month treatment period, mean ± SD PHQ-9 score decreased from 18.7 ± 5.7 to 5.0 ± 5.3, mean ± SD CGI-S score decreased from 4.4 ± 0.7 to 2.2 ± 1.1 and mean ± SD PDQ-D score decreased from 42.1 ± 18.8 to 13.4 ± 13.0. By Month 3, response and remission rates reached 80.8% and 59.0%, respectively. Work productivity loss decreased from 73.6% to 30.5%, while activity im...Continue Reading

References

Sep 15, 2001·Journal of General Internal Medicine·K KroenkeJ B Williams
May 7, 2008·Primary Care Companion to the Journal of Clinical Psychiatry·Nhu N Huynh, Roger S McIntyre
Apr 29, 2011·Occupational Medicine·S B HarveyM Hotopf
May 18, 2011·Journal of Affective Disorders·Rachel MorehouseSidney H Kennedy
Jun 15, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jong-Min WooYu Lee Park
Jul 20, 2011·The International Journal of Neuropsychopharmacology·Enric AlvarezFrancesc Artigas
Sep 18, 2012·Current Medical Research and Opinion·David S BaldwinIoana Florea
Feb 1, 2013·The International Journal of Neuropsychopharmacology·Elliott Richelson
Sep 27, 2013·CNS Spectrums·Sheri E FehnelThomas Brevig
Dec 7, 2013·Drugs·Andrew Gibb, Emma D Deeks
Mar 5, 2014·European Archives of Psychiatry and Clinical Neuroscience·Florian SeemüllerHans-Jürgen Möller
Mar 1, 2005·Current Therapeutic Research, Clinical and Experimental·Adam Keller AshtonChristine Wagoner
May 3, 2014·The International Journal of Neuropsychopharmacology·Roger S McIntyreChristina K Olsen
Jul 10, 2014·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Sakina J RizviSidney H Kennedy
Jul 13, 2014·Pharmacology & Therapeutics·Connie SanchezFrancesc Artigas
Feb 18, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Atul R MahableshwarkarRichard S E Keefe
Aug 9, 2015·World Journal of Pediatrics : WJP·Song TangGregory D Mayer
Oct 26, 2016·The Journal of Clinical Psychiatry·Roger S McIntyreMichael Cronquist Christensen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.